David Verhelst

Fanconi syndrome and renal failure induced by tenofovir: A first case report

David Verhelst, Matthieu Monge, Jean‐Luc Meynard et al. · American Journal of Kidney Diseases · 2002 · 354 citations

Medicine, Infectious Diseases, Nephrology +6

Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study

David Verhelst, Jérôme Rossert, Nicole Casadevall et al. · The Lancet · 2004 · 142 citations

Medicine, Hematology, Pharmacotherapy +11

Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial

Noémie Jourde‐Chiche, N. Costedoat‐Chalumeau, Karine Baumstarck et al. · Annals of the Rheumatic Diseases · 2022 · 86 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort

Laureline Berthelot, Agnès Jamin, Denis Viglietti et al. · Nephrology Dialysis Transplantation · 2017 · 67 citations · Full text

Life Sciences, Immunology, Nephrology +17

Rituximab alone as induction therapy for membranous lupus nephritis

Nathalie Chavarot, David Verhelst, Agathe Pardon et al. · Medicine · 2017 · 47 citations · Full text

Medicine, Immunology, Pharmacotherapy +14